36% HCW Biologics Granted FDA Clearance to Evaluate One of the Company's Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial Get link Facebook X Pinterest Email Other Apps GlobeNewswire Get link Facebook X Pinterest Email Other Apps